Table 1.: HPV Detection in Relation to Method and Clinico-Pathological Variables

Variables No. of Cases NASBA1 HPV Positive (%) Type-Specific PCR2 HPV Positive (%) ISH3 HPV Positive (%)
Age
≤ 50 85 83 (97.6) 81 (95.3) 69 (81.2)
51-70 67 59 (88.0) 61 (91.0) 51 (76.2)
>70 50 44 (88.0) 44 (88.0) 38 (76.0)
FIGO
I (IA-IB) 58 54 (93.1) 54 (93.1) 46 (79.3)
II (IIA-IIB) 82 77 (93.9) 76 (92.7) 63 (76.8)
III (IIIA-IIIB) 40 34 (85.0) 35 (87.5) 32 (80.0)
IV (IVA-IVB) 22 21 (95.5) 21 (95.5) 17 (77.3)

1 NASBA: Nucleic acid sequence based amplification; HPV 16, 18, 31, 33, 35, 45, 52, and 58 E6/E7 mRNA [25].
2 PCR: Polymerase chain reaction; HPV 16, 18, 31, 33, 35, 45, 52, and 58 DNA [25].
3 ISH: In situ hybridization; HPV 16, 18, 31 and 33 DNA [25].